Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

The US Food and Drug Administration (USFDA) questioned India's top drugmaker Sun Pharma for alleged failures in preventing ...

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

The Indian-based pharma company stated that it expects the deal to be completed during the first quarter of 2023.

An import alert may follow a warning letter or OAI classification if the FDA is not satisfied with ... subject to the exemption of certain products. Sun Pharmaceutical Industries' Halol facility ...

By Colin Kellaher India's Sun Pharmaceutical Industries Ltd. on Thursday said it agreed to buy Concert Pharmaceuticals Inc. for an initial $576 million ...

According to Sun Pharma, Palbociclib is approved by the US Food and Drugs Administration (FDA), European Medicines Agency ...

The companies have executed a definitive agreement under which Sun Pharma will acquire all outstanding shares of Concert ...

The deal is the Indian drugmaker's biggest since its $3.2 billion acquisition of generic drugmaker Ranbaxy Laboratories Ltd ...

Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma’s Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients ...